Marwan Kwok

1.5k total citations
15 papers, 881 citations indexed

About

Marwan Kwok is a scholar working on Genetics, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Marwan Kwok has authored 15 papers receiving a total of 881 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 8 papers in Oncology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Marwan Kwok's work include Chronic Lymphocytic Leukemia Research (12 papers), Lymphoma Diagnosis and Treatment (7 papers) and Cancer-related Molecular Pathways (4 papers). Marwan Kwok is often cited by papers focused on Chronic Lymphocytic Leukemia Research (12 papers), Lymphoma Diagnosis and Treatment (7 papers) and Cancer-related Molecular Pathways (4 papers). Marwan Kwok collaborates with scholars based in United Kingdom, United States and Singapore. Marwan Kwok's co-authors include Peter Hillmen, Andy C. Rawstron, Sheila J.M. O’Connor, Ruth de Tute, James A. L. Fenton, Roger G. Owen, Andrew Jack, Fiona Bennett, Marieth Plummer and Stephen J. Richards and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Blood.

In The Last Decade

Marwan Kwok

14 papers receiving 873 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marwan Kwok United Kingdom 10 522 422 320 288 277 15 881
Jennifer Edelmann Germany 12 812 1.6× 564 1.3× 257 0.8× 237 0.8× 352 1.3× 22 1.0k
Shih-Shih Chen United States 9 530 1.0× 350 0.8× 382 1.2× 127 0.4× 247 0.9× 11 850
Larry Mansouri Sweden 19 591 1.1× 397 0.9× 394 1.2× 170 0.6× 307 1.1× 37 944
Eugen Tausch Germany 18 686 1.3× 536 1.3× 308 1.0× 188 0.7× 309 1.1× 72 1.0k
Domenico Levato Italy 20 674 1.3× 461 1.1× 309 1.0× 168 0.6× 387 1.4× 29 974
Ferran Nadeu Spain 17 352 0.7× 485 1.1× 348 1.1× 332 1.2× 160 0.6× 52 925
Nadia Peragine Italy 15 310 0.6× 212 0.5× 193 0.6× 159 0.6× 269 1.0× 34 605
Alison M. McCaig United Kingdom 12 367 0.7× 252 0.6× 256 0.8× 161 0.6× 180 0.6× 17 659
Asha Ramanunni United States 8 800 1.5× 568 1.3× 310 1.0× 208 0.7× 409 1.5× 14 1.1k
Magdalena Klánová Czechia 12 252 0.5× 397 0.9× 231 0.7× 346 1.2× 130 0.5× 38 721

Countries citing papers authored by Marwan Kwok

Since Specialization
Citations

This map shows the geographic impact of Marwan Kwok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marwan Kwok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marwan Kwok more than expected).

Fields of papers citing papers by Marwan Kwok

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marwan Kwok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marwan Kwok. The network helps show where Marwan Kwok may publish in the future.

Co-authorship network of co-authors of Marwan Kwok

This figure shows the co-authorship network connecting the top 25 collaborators of Marwan Kwok. A scholar is included among the top collaborators of Marwan Kwok based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marwan Kwok. Marwan Kwok is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Kwok, Marwan, Angelo Agathanggelou, & Tatjana Stanković. (2024). DNA damage response defects in hematologic malignancies: mechanistic insights and therapeutic strategies. Blood. 143(21). 2123–2144. 7 indexed citations
2.
Kwok, Marwan & Catherine J. Wu. (2021). Clonal Evolution of High-Risk Chronic Lymphocytic Leukemia: A Contemporary Perspective. Frontiers in Oncology. 11. 790004–790004. 11 indexed citations
3.
Kwok, Marwan, Angelo Agathanggelou, Nicholas Davies, & Tatjana Stanković. (2021). Targeting the p53 Pathway in CLL: State of the Art and Future Perspectives. Cancers. 13(18). 4681–4681. 14 indexed citations
4.
Parry, Helen, Jianmin Zuo, Heather M. Long, et al.. (2019). Long-Term Ibrutinib Therapy Reverses CD8+ T Cell Exhaustion in B Cell Chronic Lymphocytic Leukaemia. Frontiers in Immunology. 10. 2832–2832. 26 indexed citations
5.
6.
Davies, Nicholas, Marwan Kwok, Ceri Oldreive, et al.. (2017). Dynamic changes in clonal cytogenetic architecture during progression of chronic lymphocytic leukemia in patients and patient-derived murine xenografts. Oncotarget. 8(27). 44749–44760. 10 indexed citations
7.
Kwok, Marwan, Andy C. Rawstron, Abraham Varghese, et al.. (2016). Minimal residual disease is an independent predictor for 10-year survival in CLL. Blood. 128(24). 2770–2773. 95 indexed citations
8.
Kwok, Marwan, Nicholas Davies, Angelo Agathanggelou, et al.. (2015). ATR inhibition induces synthetic lethality and overcomes chemoresistance in TP53- or ATM-defective chronic lymphocytic leukemia cells. Blood. 127(5). 582–595. 211 indexed citations
9.
Kwok, Marwan, Nicholas Davies, Angelo Agathanggelou, et al.. (2015). Synthetic lethality in chronic lymphocytic leukaemia with DNA damage response defects by targeting the ATR pathway. The Lancet. 385. S58–S58. 69 indexed citations
10.
Kwok, Marwan, Nicholas Davies, Angelo Agathanggelou, et al.. (2014). ATR Inhibition Exacerbates Replication Stress in TP53 or ATM Deficient CLL Cells and Enhances Sensitivity to Chemotherapy and Targeted Therapy. Blood. 124(21). 3340–3340. 1 indexed citations
11.
Kwok, Marwan, Andy C. Rawstron, Abraham Varghese, et al.. (2014). Independent prognostic significance of minimal residual disease status in chronic lymphocytic leukaemia. The Lancet. 383. S66–S66. 4 indexed citations
12.
Stanković, Tatjana, et al.. (2013). Synthetic Lethality In CLL With DNA Damage Response Defect By Targeting ATR Pathway. Blood. 122(21). 120–120. 3 indexed citations
13.
Kwok, Marwan, Andy C. Rawstron, Abraham Varghese, & Peter Hillmen. (2009). Minimal Residual Disease Is a Predictor for Progression-Free and Overall Survival in Chronic Lymphocytic Leukemia (CLL) That Is Independent of the Type or Line of Therapy.. Blood. 114(22). 540–540. 17 indexed citations
14.
Rawstron, Andy C., Fiona Bennett, Sheila J.M. O’Connor, et al.. (2008). Monoclonal B-Cell Lymphocytosis and Chronic Lymphocytic Leukemia. New England Journal of Medicine. 359(6). 575–583. 371 indexed citations
15.
Chuah, Charles, David Barnes, Marwan Kwok, et al.. (2005). Zoledronate inhibits proliferation and induces apoptosis of imatinib-resistant chronic myeloid leukaemia cells. Leukemia. 19(11). 1896–1904. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jennifer Edelmann Breakdown of academic impact, for papers by Shih-Shih Chen Breakdown of academic impact, for papers by Larry Mansouri Breakdown of academic impact, for papers by Eugen Tausch Breakdown of academic impact, for papers by Domenico Levato Breakdown of academic impact, for papers by Ferran Nadeu Breakdown of academic impact, for papers by Nadia Peragine Breakdown of academic impact, for papers by Alison M. McCaig Breakdown of academic impact, for papers by Asha Ramanunni Breakdown of academic impact, for papers by Magdalena Klánová
Rankless by CCL
2026